BAXALTA INNOVATIONS GMBH
ItalyAll drugs from this manufacturer
-
It is used for the treatment and prevention of bleeding in patients aged 12 years and older with hemophilia A, a hereditary coagulation disorder caused by a deficiency of factor VIII.
Dosage form: solution for injection, powder and solvent
Active substance Dosage rurioctocog alfa pegol - ATC: B02BD02
-
It is used to restore and maintain blood volume in patients who have lost blood or fluids due to specific medical conditions.
Dosage form: solution for infusion
Active substance Dosage human albumin - ATC: B05AA01
-
It is used to prevent and treat the formation of blood clots in adults and children aged 6 years and older who suffer from antithrombin deficiency (either congenital or acquired). It is particularly indicated during surgical procedures, pregnancy, childbirth, or in the presence of kidney disease, liver disease, or massive bleeding.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human antithrombin iii - ATC: B01AB02
-
It is used for patients with a weakened immune system who do not have a sufficient number of antibodies in the blood. It is prescribed for those with congenital antibody deficiency, for patients with chronic lymphocytic leukemia or multiple myeloma presenting with recurrent infections, and for those with reduced antibody production following a bone marrow cell transplant.
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin - ATC: J06BA01
-
It is used for the treatment and prevention of bleeding (spontaneous or related to minor surgical procedures) caused by the presence in the blood of factor VIII or factor XIa inhibitors.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human activated prothrombin complex antifilic - ATC: B02BD03
-
It is used for the treatment and prevention (prophylaxis) of bleeding episodes in people with congenital hemophilia B, a hereditary disease that causes severe bleeding in the joints, muscles, or internal organs.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human blood coagulation factor ix lyophilized - ATC: B02BD04
-
It is used to treat various conditions in which the immune system does not function correctly. It serves as antibody replacement therapy in patients with low antibody levels (such as in cases of Primary Immunodeficiency Syndrome, AIDS, chronic lymphocytic leukemia, multiple myeloma, or after stem cell transplantation) and as immune system regulation therapy in cases of Primary Immune Thrombocytopenia, Guillain-Barré Syndrome, and Kawasaki Disease.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage normal human immunoglobulin - ATC: J06BA02
-
It is used as replacement therapy for adults and children with a weak immune system that does not produce enough antibodies, and as immunomodulatory therapy for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin - ATC: J06BA01
-
It is used to treat bleeding episodes in adults with acquired hemophilia, a blood clotting disorder in which the body produces antibodies that prevent factor VIII from functioning correctly.
Dosage form: solution for injection, powder and solvent
Active substance Dosage susoctocog alfa - ATC: B02BD14
-
It is used for the treatment of bleeding, for the prevention of bleeding before or after surgery, and to treat coagulation factor deficiencies, both acquired and congenital.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human prothrombin complex - ATC: B02BD01
-
It is used for the treatment and prevention of bleeding in patients of all ages who have coagulation disorders caused by a deficiency of factors II, IX, and X. It is also indicated for liver diseases, to prevent bleeding after liver biopsies, for infants with coagulation factor deficiencies, and to manage bleeding following the use of certain anticoagulant drugs.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage coagulation factor ii - human coagulation factor ix - blood coagulation factor x - ATC: B02BD
-
It is used to treat and prevent bleeding in patients of all ages who have coagulation disorders caused by factor VII deficiency. It is indicated for both congenital and acquired disorders, for example, due to liver disease or the use of anticoagulants.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human blood coagulation factor vii lyophilized - ATC: B02BD05
-
It is used for the prevention and treatment of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Dosage form: solution for injection, powder and solvent
Active substance Dosage octocog alfa - ATC: B02BD02
-
It is used for the treatment and prevention of bleeding in patients with hemophilia B (a hereditary coagulation disorder caused by a deficiency of factor IX) of all age groups.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human coagulation factor ix - ATC: B02BD04
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (factor VIII deficiency) or with von Willebrand disease with factor VIII deficiency.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human coagulation factor viii - von willebrand factor - ATC: B02BD06
-
It is used to prevent and treat bleeding episodes, including those during surgery, in adult and pediatric patients with von Willebrand disease. In children under 18 years of age, it is indicated only for treating bleeding episodes and not for prevention or surgery.
Dosage form: solution for injection, powder and solvent
Active substance Dosage vonicog alfa - ATC: B02BD10